We are live on
!
Find out more
Ligand Pharmaceuticals
LGND
LGND
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
276
D.E. Shaw & Co
New York
| – | -$272K | -4,134 | Closed |
|
277
Millennium Management
New York
| – | -$229K | -3,610 | Closed |
|
278
Citadel Advisors
Miami,
Florida
| – | -$218K | -3,312 | Closed |
|
|
AIM
279
Acrospire Investment Management
Chicago,
Illinois
| – | -$132K | -2,082 | Closed |
|
280
VanEck Associates
New York
| – | -$26K | -404 | Closed |
|
|
TRCT
281
Tower Research Capital (TRC)
New York
| – | -$20K | -313 | Closed |
|
|
AA
282
Ancora Advisors
Cleveland,
Ohio
| – | -$15K | -240 | Closed |
|
|
PHK
283
Point72 Hong Kong
Hong Kong
| – | -$13K | -199 | Closed |
|
284
Loomis, Sayles & Company
Boston,
Massachusetts
| – | -$11K | -175 | Closed |
|
|
MMG
285
Monetary Management Group
St Louis,
Missouri
| – | -$10K | -160 | Closed |
|
286
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$197 | +3 | New |
|
|
PFO
287
Pathstone Family Office
Englewood,
New Jersey
| – | +$395 | +6 | New |
|